ARTICLE | Clinical News
Protein Design Labs, Roche regulatory update
April 15, 2013 7:00 AM UTC
The FDA's Biological Response Modifiers Advisory Committee voted unanimously (12-0) to recommend approval of the partners' Zenapax humanized anti-Tac antibody to prevent acute rejection episodes in ki...